Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|May 20, 2011
Amonafide: a potential role in treating acute myeloid leukemiaSteven L Allen, Ante S Lundberg
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 5, 2006
Interstitial lung disease following erlotinib (Tarceva) in a patient who previously tolerated gefitinib (Iressa)Kelly A Tammaro, Patricia D Baldwin, Ante S Lundberg
Biopharmaceutics & Drug Disposition|October 29, 2009
Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphateWei Yin, Elena V Karyagina, Ante S Lundberg, et al.
Leukemia Research|September 15, 2009
Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemiaSteven L Allen, Jonathan E Kolitz, Ante S Lundberg, et al.
Blood|August 24, 2011
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseasesMasha Fridkis-Hareli, Michael Storek, Istvan Mazsaroff, et al.
Molecular Immunology|December 5, 2018
The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse modelsMasha Fridkis-Hareli, Michael Storek, Eran Or, et al.
Oncogene|June 27, 2002
Immortalization and transformation of primary human airway epithelial cells by gene transferAnte S Lundberg, Scott H Randell, Sheila A Stewart, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Telomerase contributes to tumorigenesis by a telomere length-independent mechanismSheila A Stewart, William C Hahn, Benjamin F O'Connor, et al.
Blood|March 10, 2018
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locusChiara Antoniani, Vasco Meneghini, Annalisa Lattanzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemiaRichard M Stone, Emanuele Mazzola, Donna Neuberg, et al.
Pageof 1